Vertex Pharma (VRTX) Tops Q3 EPS by 8c; Offers FY19 Revenue Outlook
Tweet Send to a Friend
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.23, $0.08 better than the analyst estimate of $1.15. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
